Cargando…
Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma
Clear Cell Renal Carcinoma (ccRCC) accounts for nearly 80% of renal carcinoma cases, and immunotherapy plays an important role in ccRCC therapy. However, the responses to immunotherapy and overall survival for ccRCC patients are still hard to predict. Here, we constructed an immune-related predictiv...
Autores principales: | Hua, Shan, Xie, Zhiwen, Zhang, Yongqing, Wu, Lei, Shi, Fei, Wang, Xingjie, Xia, Shujie, Dong, Shengli, Jiang, Juntao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352939/ https://www.ncbi.nlm.nih.gov/pubmed/35936012 http://dx.doi.org/10.3389/fimmu.2022.869297 |
Ejemplares similares
-
External Validation of the Prognostic Value of an Immune-Associated Gene Panel for Clear Cell Renal Cell Carcinomas
por: Xie, Zhiwen, et al.
Publicado: (2021) -
Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma
por: Liu, Yankuo, et al.
Publicado: (2023) -
Development and Validation of Prognostic Model in Transitional Bladder Cancer Based on Inflammatory Response-Associated Genes
por: Xie, Zhiwen, et al.
Publicado: (2021) -
Identification of Feature Genes of a Novel Neural Network Model for Bladder Cancer
por: Zhang, Yongqing, et al.
Publicado: (2022) -
A nomogram for predicting the risk of residual stone fragments after ureteroscopy
por: Zhang, Yongqing, et al.
Publicado: (2023)